Inclusion of secondary chronic myelomonocytic leukemia and myeloproliferative disease, unclassifiable, in classification of pediatric myeloproliferative disorders

J Pediatr Hematol Oncol. 2006 Oct;28(10):700-1. doi: 10.1097/01.mph.0000243643.13369.63.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Child
  • Chromosome Aberrations
  • Chromosomes, Human, Pair 7 / genetics*
  • Clone Cells
  • Disease Progression
  • Fatal Outcome
  • Female
  • Humans
  • Leukemia, Myelomonocytic, Chronic / diagnosis*
  • Leukemia, Myelomonocytic, Chronic / genetics
  • Leukemia, Myelomonocytic, Chronic / therapy
  • Myeloproliferative Disorders / classification*
  • Myeloproliferative Disorders / genetics
  • Myeloproliferative Disorders / therapy
  • Neoplasms, Second Primary / diagnosis*
  • Neoplasms, Second Primary / genetics
  • Neoplasms, Second Primary / therapy
  • Recurrence